Clinical Trial Update: Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update shows efficacy and safety data for TriMix, a multiple-action tear substitute, in dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• TriMix

Snippet

Sponsor: University of Seville | Conditions: Dry Eye | Phase 2, Phase 3 | Status: COMPLETED